Page 50 - Read Online
P. 50
Della Porta et al. Comparison of p53 and prohibitin expression
infection. Folia Histochem Cytobiol 2009;47:35-42. 32. Theiss AL, Jenkins AK, Okoro NI, Klapproth JM, Merlin D,
28. Webster GA, Perkins ND. Transcriptional cross talk between NF- Sitaraman SV. Prohibitin inhibits tumor necrosis factor alpha-
kappaB and p53. Mol Cell Biol 1999;19:3485-95. induced nuclear factor-kappa B nuclear translocation via the novel
29. Fusaro G, Dasgupta P, Rastogi S, Joshi B, Chellappan S. Prohibitin mechanism of decreasing importin alpha3 expression. Mol Biol Cell
induces the transcriptional activity of p53 and is exported from the 2009;20:4412-23.
nucleus upon apoptotic signaling. J Biol Chem 2003;278:47853-61. 33. Sánchez-Quiles V, Santamaría E, Segura V, Sesma L, Prieto J,
30. Theiss AL, Sitaraman SV. The role and therapeutic potential of Corrales FJ. Prohibitin deficiency blocks proliferation and induces
prohibitin in disease. Biochim Biophys Acta 2011;1813:1137-43. apoptosis in human hepatoma cells: molecular mechanisms and
31. Theiss AL, Vijay-Kumar M, Obertone TS, Jones DP, Hansen JM, functional implications. Proteomics 2010;10:1609-20.
Gewirtz AT, Merlin D, Sitaraman SV. Prohibitin is a novel regulator 34. Wang S, Fusaro G, Padmanabhan J, Chellappan SP. Prohibitin co-
of antioxidant response that attenuates colonic inflammation in mice. localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for
Gastroenterology 2009;137:199-208. transcriptional repression. Oncogene 2002;21:8388-96.
42 Hepatoma Research ¦ Volume 3 ¦ February 28, 2017
